• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测高血压性心脏病患者心脏淀粉样变性的IWT评分

IWT score for predicting cardiac amyloidosis in patients with hypertensive heart disease.

作者信息

Matsumoto Yuna, Ichikawa Naoko, Matsuzawa Yuina, Saito Sachika, Niinuma Hiroyuki, Aoki Jiro, Komiyama Nobuyuki

机构信息

Clinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.

Clinical Laboratory, St. Luke's International Hospital, 9-1 Akashi Chuo-ku, Tokyo, Tokyo, 104-8560, Japan.

出版信息

Int J Cardiovasc Imaging. 2025 Sep 15. doi: 10.1007/s10554-025-03517-4.

DOI:10.1007/s10554-025-03517-4
PMID:40952633
Abstract

PURPOSE

Early detection and treatment of cardiac amyloidosis (CA) are essential to improve prognosis, following recent therapeutic advances. Therefore, echocardiographic evaluation is crucial, and an increased wall thickness (IWT) score was proposed in 2020. 35% of patients with CA were previously diagnosed with other cardiomyopathies, such as Hypertensive Heart Disease (HHD). However, using the IWT score for all patients with left ventricular wall thickening remains controversial. In this study, we investigated characteristic IWT score patterns in patients with HHD.

METHODS

We assessed patients with HHD who underwent echocardiography between August and November 2024. IWT scores were calculated using transthoracic echocardiography. Two groups were compared: mild and moderate-to-severe left ventricular hypertrophy (LVH). Logistic regression analysis was conducted for mild LVH cases with IWT scores between 2 and 7 points (suspected CA, gray zone) to analyze parameters that influenced this classification.

RESULTS

Among 121 patients (mean age: 60.3 ± 11.5 years), 84 (69%), 23 (19%), and 14 (12%) had mild, moderate and severe LVH, respectively. Sixty-two (51%) patients fell into the gray zone. Significant factors affecting IWT score included the systolic apex-to-base ratio (SAB) (Odds ratio [OR] = 42.4, p < 0.001), relative wall thickness (RWT) (OR = 5.0, p = 0.022), and tricuspid annular plane systolic excursion (TAPSE) (OR = 22.5, p < 0.001). Modifying the SAB formula and establishing a TAPSE cutoff value of 17 mm decreased the number of gray zone cases to 35 (29%).

CONCLUSION

Half of the patients with HHD demonstrated IWT scores consistent with suspected CA.

摘要

目的

随着近期治疗进展,心脏淀粉样变性(CA)的早期检测和治疗对于改善预后至关重要。因此,超声心动图评估至关重要,2020年提出了增加壁厚度(IWT)评分。35%的CA患者此前被诊断为其他心肌病,如高血压性心脏病(HHD)。然而,将IWT评分用于所有左心室壁增厚患者仍存在争议。在本研究中,我们调查了HHD患者的特征性IWT评分模式。

方法

我们评估了2024年8月至11月期间接受超声心动图检查的HHD患者。使用经胸超声心动图计算IWT评分。比较了两组:轻度和中度至重度左心室肥厚(LVH)。对IWT评分为2至7分(疑似CA,灰色区域)的轻度LVH病例进行逻辑回归分析,以分析影响该分类的参数。

结果

在121例患者(平均年龄:60.3±11.5岁)中,分别有84例(69%)、23例(19%)和14例(12%)患有轻度、中度和重度LVH。62例(51%)患者属于灰色区域。影响IWT评分的显著因素包括收缩期心尖至心底比值(SAB)(比值比[OR]=42.4,p<0.001)、相对壁厚度(RWT)(OR=5.0,p=0.022)和三尖瓣环平面收缩期位移(TAPSE)(OR=22.5,p<0.001)。修改SAB公式并将TAPSE临界值设定为17 mm可将灰色区域病例数减少至35例(29%)。

结论

一半的HHD患者表现出与疑似CA一致的IWT评分。

相似文献

1
IWT score for predicting cardiac amyloidosis in patients with hypertensive heart disease.预测高血压性心脏病患者心脏淀粉样变性的IWT评分
Int J Cardiovasc Imaging. 2025 Sep 15. doi: 10.1007/s10554-025-03517-4.
2
Regional Analysis of Myocardial Strain to Wall Thickness Ratio in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy.心肌应变与心肌厚度比值在心脏淀粉样变性和肥厚型心肌病中的区域性分析。
J Thorac Imaging. 2024 Jul 1;39(4):255-264. doi: 10.1097/RTI.0000000000000772. Epub 2024 Jan 9.
3
Results of a Screening Program for Diagnosis of Amyloid Cardiomyopathy Among Patients with Left Ventricular Hypertrophy: PAPCAT Cardiac Amyloidosis Türkiye Survey.左心室肥厚患者中淀粉样心肌病诊断筛查项目的结果:PAPCAT心脏淀粉样变土耳其调查
Anatol J Cardiol. 2025 Aug 14. doi: 10.14744/AnatolJCardiol.2025.4942.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Systemic Inflammatory Response Syndrome全身炎症反应综合征
6
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
7
Prognostic value of baseline RV dysfunction using TAPSE and TAPSE to PASP ratio in patients undergoing mitra-clip: a systematic review and meta-analysis.使用三尖瓣环平面收缩期位移(TAPSE)及TAPSE与肺动脉收缩压(PASP)比值评估接受二尖瓣夹合术患者基线右心室功能障碍的预后价值:一项系统评价和荟萃分析
Int J Cardiovasc Imaging. 2025 May;41(5):827-846. doi: 10.1007/s10554-025-03354-5. Epub 2025 Mar 22.
8
Evaluation of Left Atrial Function in Patients with Hypertensive Heart Disease and Preserved Ejection Fraction Using Real-Time, Three- Dimensional Speckle Tracking Imaging.使用实时三维斑点追踪成像评估射血分数保留的高血压性心脏病患者的左心房功能
Kardiologiia. 2025 Sep 10;65(8):63-70. doi: 10.18087/cardio.2025.8.n2856.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Home versus in-centre haemodialysis for people with kidney failure.居家透析与中心透析治疗肾衰竭患者的效果比较。
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD009535. doi: 10.1002/14651858.CD009535.pub3.

本文引用的文献

1
Comparing Echocardiographic Strain Imaging in Cardiac Amyloid and End-Stage Renal Disease Patients.比较心脏淀粉样变和终末期肾病患者的超声心动图应变成像。
Echocardiography. 2024 Oct;41(10):e15962. doi: 10.1111/echo.15962.
2
Echocardiographic assessment of left ventricular mechanics in individuals with mitral valve prolapse: a systematic review and meta-analysis.超声心动图评估二尖瓣脱垂患者左心室力学:系统评价和荟萃分析。
Int J Cardiovasc Imaging. 2024 Aug;40(8):1617-1629. doi: 10.1007/s10554-024-03179-8. Epub 2024 Jul 8.
3
Prognostic Implications of Left Ventricular Hypertrophy and Mechanical Function in Fabry Disease: A Longitudinal Cohort Study.
法布瑞病患者左心室肥厚和机械功能的预后意义:一项纵向队列研究。
J Am Soc Echocardiogr. 2024 Aug;37(8):787-796. doi: 10.1016/j.echo.2024.04.010. Epub 2024 May 3.
4
Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography.心脏“肥厚”的表型分析:通过超声心动图鉴别左心室壁厚度增加的病因
Front Cardiovasc Med. 2023 Jul 3;10:1183485. doi: 10.3389/fcvm.2023.1183485. eCollection 2023.
5
Prognostic Value of Apical Sparing of Longitudinal Strain in Patients with Symptomatic Aortic Stenosis.有症状主动脉瓣狭窄患者纵向应变心尖保留的预后价值
Acta Cardiol Sin. 2022 May;38(3):341-351. doi: 10.6515/ACS.202205_38(3).20211209A.
6
Myocardial strain in hypertension: a meta-analysis of two-dimensional speckle tracking echocardiographic studies.高血压患者的心肌应变:二维斑点追踪超声心动图研究的荟萃分析。
J Hypertens. 2021 Oct 1;39(10):2103-2112. doi: 10.1097/HJH.0000000000002898.
7
Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.基于心脏磁共振的标志物对肥厚型心肌病患者的预后意义。
Int J Cardiovasc Imaging. 2021 Jun;37(6):2027-2036. doi: 10.1007/s10554-021-02165-8. Epub 2021 Feb 8.
8
Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain.超声心动图对左心室肥厚的鉴别诊断的疗效:特别关注斑点追踪纵向应变。
J Echocardiogr. 2021 Jun;19(2):71-79. doi: 10.1007/s12574-020-00508-3. Epub 2021 Jan 18.
9
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).日本高血压学会高血压管理指南(JSH 2019)。
Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9.
10
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.淀粉样变命名 2018:国际淀粉样变学会(ISA)命名委员会的建议。
Amyloid. 2018 Dec;25(4):215-219. doi: 10.1080/13506129.2018.1549825. Epub 2019 Jan 7.